top of page
LGMD2L Foundation-Hero.jpg

Help us find a cure for those living with LGMD2L

LGMD2L refers to the condition also called LGMDR12 under a revised naming system developed to standardize muscular dystrophy classification. Learn more

LGMD2L Foundation-Mike Martin.jpg

“We are a diverse community. I draw strength from everyone’s stories. None of us asked for the hand we were dealt, but together we can play our cards in a way that will let us live life well.”

Mike Martin

Princeton, NJ, United States

LGMD2L is a rare genetic disorder affecting up to 1 in 60,000 people worldwide.
The disease causes progressive muscle weakness making daily activities difficult.
There is no cure for LGMD2L but research is uncovering potential treatments.

We’re advancing research for LGMD2L

Through strategic funding, expert collaboration, and innovative research, we’re working to support those affected by LGMD2L and drive progress toward a cure.

LGMD2L Foundation-Research.jpg

Why do we fund research?

LGMD2L is under-researched, making progress towards treatments slow. By funding foundational research, we aim to bridge this gap for both researchers and patients.

LGMD2L Foundation-Institution.jpg

How do we fund research?

Our funding focuses on collaboration with experts in academia, public, and private sectors to drive breakthroughs in LGMD2L research.

LGMD2L Foundation-Research Team.jpg

What research are we funding?

We fund initiatives to improve care, understand causes, and explore therapies for LGMD2L, laying the foundation for better treatment and potential cures.

Your support can make a difference today.

Help us accelerate research and bring hope to those living with LGMD2L.

Phone: (224) 392-5420

© 2025 LGMD2L Foundation. All rights reserved.

bottom of page